Litcius/Paper detail

Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases

Zhiqin Ji, Richard F. Clark, Vikram Bhat, Terkel Hansen, Loren Lasko, Kenneth D. Bromberg, Vlasios Manaves, Mikkel A. Algire, Ruth L. Martin, Wei Qiu, Maricel Torrent, Clarissa G. Jakob, Hong Liu, Philip A. Cole, Ronen Marmorstein, Edward A. Kesicki, Albert Lai, Michael R. Michaelides

2021Bioorganic & Medicinal Chemistry Letters22 citationsDOIOpen Access PDF

Topics & Concepts

Histone AcetyltransferasesChemistryHistone acetyltransferaseAcetyltransferaseCREB-binding proteinAcetylationAcetyltransferasesHistoneP300-CBP Transcription FactorsPCAFBiochemistryHistone deacetylaseEnzymeCREBPharmacologyTranscription factorBiologyGeneProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysGenomics and Chromatin Dynamics
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases | Litcius